Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 111 are a BUY (91.74%), 10 are a HOLD (8.26%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 53.32% that have a potential upside of 32.96% achieved within 121 days.
Marie Thibault’s has documented 243 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 18-Jul-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$145
$18.46 (14.59%)
$137
12 days ago
(18-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
365
Hold
$135
$8.46 (6.69%)
$140
12 days ago
(18-Jul-2025)
5/7 (71.43%)
$11.33 (9.16%)
122
Buy
$145
$18.46 (14.59%)
$139
12 days ago
(18-Jul-2025)
8/9 (88.89%)
$21.33 (17.25%)
759
Buy
$145
$18.46 (14.59%)
$124
22 days ago
(08-Jul-2025)
7/8 (87.5%)
$11.64 (8.73%)
316
Buy
$145
$18.46 (14.59%)
$133
3 months 13 days ago
(17-Apr-2025)
2/3 (66.67%)
$14.02 (10.70%)
133
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?